Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level

Amparo Santamaría, Antonio Martínez-Rubio, Montserrat Borrell, José Mateo, Rosa Ortín, Jordi Fontcuberta

    Research output: Contribution to journalArticleResearchpeer-review

    40 Citations (Scopus)

    Abstract

    To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.
    Original languageEnglish
    Pages (from-to)880-881
    JournalHaematologica
    Volume89
    Issue number7
    Publication statusPublished - 1 Jul 2004

    Keywords

    • Arterial
    • Coronary
    • TAFI
    • Thrombosis

    Fingerprint Dive into the research topics of 'Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level'. Together they form a unique fingerprint.

    Cite this